Delhi Drugs Control Department Seizes Insulin Stock Worth Rs 20.06 Lakh

New Delhi (ANI): The Delhi Drugs Control Department conducted a special enforcement drive at a wholesale drug market in Delhi to ensure the availability of safe, effective and quality medicines to the public, particularly insulin preparations that require strict cold chain maintenance.

During the inspection, a total of six wholesale drug firms were inspected, out of which four firms were found violating provisions of the Drugs and Cosmetics Act, 1940 and the Drugs Rules, 1945. A large quantity of insulin preparations, including Tresiba FlexTouch 100U/ml Pen, Glaritus 100U/ml Cartridges, Humalog Mix50 KwikPen 100U/ml, Apidra SoloStar 100U/ml and Toujeo SoloStar 300U/ml, were found stocked with defaced inscriptions on labels that are meant for Government or institutional supply.

The concerned firms failed to produce valid purchase records for the said stock. Additionally, two firms were found storing insulin preparations at normal room temperature, in violation of prescribed storage conditions that mandate strict cold chain maintenance.

In total, 2,104 units of insulin preparations worth ₹20,06,024 were seized during the enforcement drive.

Speaking on the action, Delhi Health Minister Pankaj Kumar Singh said, “Ensuring the availability of safe and effective medicines for citizens is our foremost priority. Under the leadership of Hon’ble Chief Minister Smt. Rekha Gupta, the Delhi Government, is committed to maintaining strict regulatory oversight on drug storage and distribution. Any violation involving life-saving medicines like insulin will invite strict action under the law.”

Following the inspection, two firms have been booked for violations under the relevant provisions of the Drugs and Cosmetics Act, 1940 and the Drugs Rules, 1945. Additionally, drug samples have been collected and sent for testing and analysis to verify their quality and compliance with prescribed standards.

The Delhi Drugs Control Department reiterated its commitment to safeguarding public health and ensuring strict compliance with statutory provisions related to the storage and distribution of life-saving medicines. (ANI)

SOURCE : ANI

Related Posts

Zydus Lifesciences Q4FY26 net profit rises 9%

Zydus board approved a buyback of up to Rs 1100 crore at Rs 1,150 per share, along with a 100 percent dividend for FY26. Zydus Lifesciences reported a rise in…

Chemists strike on May 20: Reasons behind today’s all-India strike

While major pharmacy chains and government medical outlets will remain operational, the strike highlights significant tensions within the industry that could impact access to medications nationwide. The All India Organisation…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Zydus Lifesciences Q4FY26 net profit rises 9%

Zydus Lifesciences Q4FY26 net profit rises 9%

Chemists strike on May 20: Reasons behind today’s all-India strike

Chemists strike on May 20: Reasons behind today’s all-India strike

AbbVie loses patent plea for Hep C drug

AbbVie loses patent plea for Hep C drug

GSK’s Calpol a well-known trademark: High Court

GSK’s Calpol a well-known trademark: High Court

3 arrested for allegedly posing as doctors using forged MBBS degrees

3 arrested for allegedly posing as doctors using forged MBBS degrees

Commissioner FDA reviews enforcement measures

Commissioner FDA reviews enforcement measures